Cayuga Biotech
Cayuga Biotech, a clinical-stage biopharmaceutical company, is developing novel therapies to address life-threatening hemorrhage by harnessing the body’s innate ability to stop bleeding. Cayuga’s pipeline includes clinical-stage CAY001 (polyP-SNP complex), in development for acute major hemorrhage, CAY002, a discovery-stage program for inherited bleeding disorders and a portfolio of early-stage programs across the healing continuum. To learn more, please visit
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
11
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Cayuga Biotech
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Cayuga Biotech
1 distinct titles indexed · top 1 shown.
- 1member board of directors (observer)
Sign up to unlock all 2 contacts at Cayuga Biotech
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Cayuga Biotech
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.